OPTI FINANCIAL2.png
  • Home

  • Blog

    • Stocks Glossary
  • Team

    • Team
  • Subscribe

  • More...

    Use tab to navigate through the menu items.

    OptiFinancial

    Weekly Stock Picks Newsletter

    • All Posts
    • Progenity
    • Butterfly Network
    • Camber Energy
    • Momentus Space
    • World Event
    Search
    PROG | Catalyst Details
    Brad Mitchell
    • Apr 17
    • 5 min

    PROG | Catalyst Details

    Details on P2a and exactly what it is.
    1,231 views0 comments
    PROG | Sponsors / Upcoming Abstracts
    Brad Mitchell
    • Apr 10
    • 3 min

    PROG | Sponsors / Upcoming Abstracts

    Update on the Abstracts & Sponsors. Abstracts will be posted before July 13th
    483 views0 comments
    PROG | Earnings Reflection & OBDS industry explanation
    Brad Mitchell
    • Apr 4
    • 6 min

    PROG | Earnings Reflection & OBDS industry explanation

    Relfection on earnings, and exactly why industry will use the OBDS like candy
    720 views0 comments
    PROG | Preecludia Validated
    Brad Mitchell
    • Mar 20
    • 5 min

    PROG | Preecludia Validated

    Preecludia uncertainty is no longer. The product has been reviewed and Progenity's credibility is restored
    1,273 views0 comments
    PROG | DDS Update
    Brad Mitchell
    • Mar 13
    • 6 min

    PROG | DDS Update

    Insights onto the multi-billion dollar product lines of Progenity. Update on their progress from their flagship therapeutic pill.
    1,310 views1 comment
    PROG | Pill of the future, new drug combinations
    Brad Mitchell
    • Feb 20
    • 7 min

    PROG | Pill of the future, new drug combinations

    IL6 suppressant (Tocilizumab) could potentially be used with Progenity's pill to capture $2.5 Billion Annually. DDS | Future applications
    804 views1 comment
    PROG | Future timeline and revenue
    Brad Mitchell
    • Jan 2
    • 3 min

    PROG | Future timeline and revenue

    This shows the analysis of the future revenue of Progenity and future share price
    1,831 views0 comments
    PROG | Understanding topline results before release this week
    Brad Mitchell
    • Dec 26, 2021
    • 9 min

    PROG | Understanding topline results before release this week

    Description of the studies for you knowledge and how it will effect share price upon release of results
    2,242 views0 comments
    PROG | Stock to double on upcoming topline results
    Brad Mitchell
    • Dec 19, 2021
    • 8 min

    PROG | Stock to double on upcoming topline results

    Data is around the corner, details on what to look for and what to expect. Why this pill tech will disrupt healthcare
    2,835 views0 comments
    PROG Wednesday Night Twitter Call 12.08.21
    Brad Mitchell
    • Dec 8, 2021
    • 2 min

    PROG Wednesday Night Twitter Call 12.08.21

    Itinerary and landing page to discussion of Progenity every wednesday evening at 7pm central time. Audio recording is uploaded afterwards
    637 views0 comments
    PROG's 4 horsemen to healthcare | Starts with December data
    Brad Mitchell
    • Dec 5, 2021
    • 14 min

    PROG's 4 horsemen to healthcare | Starts with December data

    The future timeline for the adoption of Progenity's products. S-curve uptrend starts this December.
    3,488 views0 comments
    Itinerary | PROG Wednesday Night Twitter Call
    Brad Mitchell
    • Nov 30, 2021
    • 46 min

    Itinerary | PROG Wednesday Night Twitter Call

    Itinerary for upcoming Twitter Spaces call
    768 views0 comments
    3 Tech Pills & Catalyst Timelines
    Brad Mitchell
    • Nov 28, 2021
    • 10 min

    3 Tech Pills & Catalyst Timelines

    Clarification on the product lines for Progenity and near term catalysts in the future.
    5,613 views0 comments
    Progenity | Upcoming catalysts, competition is good news
    Brad Mitchell
    • Nov 21, 2021
    • 6 min

    Progenity | Upcoming catalysts, competition is good news

    Progenity to dominate the market during end of year. Price appreciation is on the horizon due to market reevaluation and catalysts ahead.
    1,685 views0 comments
    Progenity | PT $25, Buyout $56,  no short squeeze or chart analysis, Just Value
    Brad Mitchell
    • Nov 7, 2021
    • 12 min

    Progenity | PT $25, Buyout $56, no short squeeze or chart analysis, Just Value

    Optifinancial Newsletter - Knowledge is power - Brad Mitchell This is not financial advice nor recommendations. This is purely our own...
    15,656 views0 comments
    Progenity Inc: A possible short squeeze to $15
    Brad Mitchell
    • Oct 3, 2021
    • 8 min

    Progenity Inc: A possible short squeeze to $15

    IN THIS ISSUE Progenity $1.79 Possible short squeeze ahead, alongside strong disruptive technology in the medical field. Look at my last...
    2,497 views0 comments
    Progenity and Ethereum
    Brad Mitchell
    • Sep 5, 2021
    • 6 min

    Progenity and Ethereum

    IN THIS ISSUE Progenity This small biotechnology company has fallen from $15 a share to $1 a share in one year. We think this can go to...
    2,296 views0 comments
    Progenity and Disney
    Brad Mitchell
    • Jul 18, 2021
    • 7 min

    Progenity and Disney

    IN THIS ISSUE Progenity This company is developing groundbreaking medical technology. Learn why we think now is a good time to buy....
    222 views0 comments
    Progenity Inc.
    Brad Mitchell
    • May 30, 2021
    • 7 min

    Progenity Inc.

    Please subscribe to us, we are worth your time and will keep you informed! RECAP OF LAST WEEK AND RESULTS: Cassava Sciences This company...
    2,062 views0 comments

    FREE Weekly Newsletter

    Thanks so much for submitting! We are excited for you to find value from this letter!

    Monthly Stock Research Letter

    PURCHASE NOW
    • Stocktwits logo
    • Twitter

    © 2020 Proudly Created By Ethan Mitchell